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ABSTRACT The nuclear factor of activated T-cell (NFAT) transcription factors play an important role in many biological
processes, including pathological cardiac hypertrophy. Stimulated by calcium signals, NFAT is translocated to the nucleus where
it can regulate hypertrophic genes (excitation-transcription coupling). In excitable cells, such as myocytes, calcium is a key
second messenger for multiple signaling events, including excitation-contraction coupling. Whether the calcium signals due to
excitation-contraction and excitation-transcription coupling coincide or how they can be differentiated is currently unclear.
Here we construct a mathematical model of NFAT cycling ﬁtted to skeletal myocyte and baby hamster kidney cell data. The
model replicates key behavior with respect to sensitivity to calcineurin overexpression and to calcium oscillations. Finally, we
measure the sensitivity of the system to a simulated hypertrophic calcium signal, against a background excitation-contraction
coupling calcium oscillation. We ﬁnd that NFAT cycling is sensitive to excitation-transcription coupling even when both calcium
signals are in the same cellular compartment, thus showing that separation of the signals may not be necessary in vitro.INTRODUCTION
The nuclear factor of activated T cell (NFAT) transcription
factors are important in a number of signal transduction path-
ways, having been implicated in a diverse range of functions
such as bone maintenance (1), memory formation (2),
immune response (3), and cell differentiation (4). NFAT is
also involved in pathological cardiac hypertrophy (5), which
in turn is a risk factor for heart failure (6).
While NFAT binds only weakly with DNA, it interacts
with a range of other factors stimulated from multiple intra-
cellular pathways to accomplish hypertrophic gene expres-
sion (7). Thus NFAT complexes function as crucial ‘‘signal
integrators’’ (8) for the progression of the disease.
NFAT resides in the cytoplasm until it is dephosphory-
lated by calcineurin, in response to a calcium signal. During
dephosphorylation, calcineurin binds to NFAT and the
complex is translocated into the nucleus. There NFAT can
bind to DNA and upregulate hypertrophic genes, before
being rephosphorylated and exported from the nucleus in
what appears to be a ‘‘futile cycle’’.
In this article, we develop a generic mathematical model
for NFAT cycling on activation of calcineurin, using data
from mouse skeletal muscle and baby hamster kidney
(BHK) cells. We apply this model to the consideration of
the cardiac myocyte. The stimulation of NFAT cycling by
calcium in the cardiac myocyte raises significant questions
about how two calcium signals may be differentiated by
the cell—the first due to excitation-contraction coupling
(calcium-induced calcium release) in the beating myocyte,
and the second due to a rise in calcium from hypertrophic
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0006-3495/09/03/2095/10 $2.00signal transduction. Understanding how the cell can respond
to a calcium signal induced by hypertrophic signal transduc-
tion when intracellular calcium is also oscillating has been
recognized as a significant challenge in cardiac calcium
research (9), leading to the hypothesis that the two calcium
signals may be localized to different compartments in the
cell.
Here we use our model to explore whether such compart-
mentalization is necessary, using the information currently
available on NFAT translocation kinetics. We have already
employed such modeling to reveal insights about the hyper-
trophic pathway upstream of NFAT (10), and in recent years,
a number of mathematical models have been constructed to
explore facets of NFAT cycling. Shen et al. (11) explored
the role of kinases in the nuclear export process in skeletal
muscle. While their model revealed useful insights, it is
phenomenologically based and not easily extended to
a general exploration of NFAT cycling. A more biophysi-
cally based model is presented by Fisher et al. (12), which
focuses on the role of the cotranslocation of calcineurin
into the nucleus in T lymphocytes. Arron et al. (13) presented
an extended NFAT cycling model, but the timescale consid-
ered is much longer than is required here (being approxi-
mately hours), as they explore the possible feedback of
NFAT-stimulated gene expression on cytosolic NFAT
dephosphorylation. Shin et al. (14) presented an NFAT
cycling model postulating the dual regulatory role of an
endogenous inhibitor. While useful, this model required
a large number (>15) of estimated parameters. Given the
lack of data in this part of the pathway, a parsimonious
approach to model formulation seems appropriate. Tomida
et al. (15) took such an approach in their investigation of
the effect of calcium oscillations in BHK cells. However,
none of these models addresses the question of interest here.
doi: 10.1016/j.bpj.2008.11.064
2096 Cooling et al.To explore the likely effect of calcium signaling in cardiac
myocyte NFAT cycling, a parsimonious mathematical model
consisting of the core NFAT cycling reactions is developed.
The model has six unknown parameters which are fitted by
constraining the model to the mouse skeletal myocyte data
from Shen et al. (11) (cardiac myocyte-specific data being
unavailable), and BHK-derived transient data from Tomida
et al. (15). The model exhibits similar effects to those
observed in the NFAT cycle in Jurkat T lymphocytes,
showing a cytosolic buildup of dephosphorylated NFAT,
and proves to be more efficient when subjected to an oscil-
lating calcium signal than a constant signal, at low average
calcium concentrations. Thus, it provides a plausible descrip-
tion of how this cycle works in general, and therefore in the
cardiac myocyte on stimulation by calcium signals.
Once constructed, the model is used to determine how large
a signal might be required from signal transduction to stimu-
late increased NFAT cycling, given that an oscillating signal
(from excitation-contraction coupling) is already present. In
particular, the question of whether a cytosolic signal trans-
duction-induced signal gets washed-out by an oscillating
cytosolic calcium signal is explored.
METHODS
NFAT cycling model formulation
The mathematical model of the NFAT cycle developed here is shown in
schematic form in Fig. 1. The phosphatase calcineurin is complexed with
calmodulin (together referred to asN for the purposes of this model), and acti-
FIGURE 1 Schematic of the NFAT cycling model. Calcium (Ca) and
calmodulin (not shown) activates calcineurin (N), which binds to and
dephosphorylates cytosolic NFAT (NFATpc). The calcineurin-bound cyto-
solic NFAT (NFATNc) translocates to the nucleus where it (now NFATNn)
can bind DNA cooperatively with other factors to transcribe hypertrophic
genes. NFAT may also be rephosphorylated (to NFATpn), and exported
from the nucleus in an apparent ‘‘futile cycle’’.
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lates cytosolic NFAT (NFATpc), forming a cytosolic dephosphorylated
complex (NFATNc) via reaction R1. The dephosphorylation causes the expo-
sure of a nuclear localization signal domain (16) on NFAT, leading to the
binding of importins and ferrying of NFAT through nuclear pores via the
Ran cycle (17) into the nucleus (reaction R2). Nuclear dephosphorylated
NFAT (NFATNn) is free to bind to the DNA (hence, is DNA-ready) cooper-
atively with other transcription factors and invoke a hypertrophic response.
Inside the nucleus there are a number of kinases that rephosphorylate
NFAT (shown by reaction R3), and it is thought that the primary enzymes
in myocytes are GSK-3b, CK1, and CK2 (11). This phosphorylation of
nuclear NFAT (to NFATpn) is inhibited by the complexed activated calci-
neurin, which is cotranslocated with NFAT into the nucleus (18). Hence,
NFAT cycling is also affected by nuclear calcium, due to its inhibition of
NFAT rephosphorylation via continued calcineurin activation. Once NFAT
is rephosphorylated, a nuclear export signal domain is exposed (19), and
NFAT is exported from the nucleus (shown as reaction R4), via exportins
and the Ran cycle, to become cytosolic phosphorylated NFAT (NFATpc)
again.
The model consists of molecular species in two compartments—the
cytosol and the nucleus. In rat ventricular and mouse atrial cells, the nucleus
is ~2% of cell volume (Table 3 in Bers (20)). This is included in the model
by a conversion factor Ccn (converting cytosolic molar fluxes to nuclear
molar fluxes) set at 50.
To make a parsimonious yet biologically meaningful model, a number of
simplifying assumptions were made. Since the timescale of calcium-depen-
dent calcineurin activation and deactivation when calcium is varied
(seconds, as in (21) and (22), respectively) is much faster than NFAT trans-
location (tens of minutes (11)), we employ a steady-state calcineurin activa-
tion model, in which calcineurin activation is instantaneous with increasing
calcium. The assumption is made here that calcium ions can freely diffuse
freely into the nucleus via nuclear pores (23), consistent with experimental
findings (24), and that the timescale is sufficiently fast compared to NFAT
translocation (being in the order of hundreds of milliseconds in rat leukemia
cells (25)) that nuclear calcium can be assumed to be equal to cytosolic
calcium. Without any information to the contrary, it is also assumed that
for the purposes of calcineurin activation, the total calmodulin concentration
inside the nucleus is equal to that in the cytosol. To test the effect of these
assumptions on our model, we also conducted a sensitivity analysis for
the nuclear calcium, nuclear calmodulin, and the ratio of cytosolic/nuclear
volume. We varied each parameter by 50%, 10%, þ10%, and þ50%
of their original values and checked our fits to the datasets derived by
Shen et al. (11) and Tomida et al. (15) (see Supporting Material). Due to
the protocols used, model fits were insensitive to these parameters, and
our model predictions in response to calcium stimulations were conserved.
Importins, exportins, and Ran cycle component concentrations are
assumed to be sufficiently constant so as not to be rate-affecting, and therefore
do not require explicit modeling as separate molecular pools. Concentrations
of these species are instead abstracted into the rate constants for the reactions
that use them: reaction R2 for nuclear import, and R4 for nuclear export.
It is assumed that any synthesis of NFAT is balanced by degradation, and
that (on the timescale of the simulation) the total amount of NFAT available
in the cell is constant at 1 mM. Since this model will be fitted to data
measuring relative NFAT species proportions, knowledge of the exact
concentration is not critical.
The details of GSK-3b, CK1 and CK2 kinases, and perhaps other priming
kinases such as PKA (26), are not known with enough detail to model them
TABLE 1 Nact variation with increasing CaSigTrans
CaSigTrans nM Average calcium nM Average pCa Average Nact %
None 154 6.82 2.00
100 254 6.60 8.07
250 404 6.39 25.4
500 654 6.18 58.2
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in the nucleus and provide a rephosphorylation rate by virtue of lumped rate
constants for reaction R3.
The NFAT phosphorylation and dephosphorylation reactions are both
modeled as single steps, although in reality there may be a large number
of phosphorylation sites involved. Research suggests there may be 14
sites in all and perhaps 13 of these are dephosphorylated during NFAT
cycling (27). There is currently no conclusive evidence pointing to exactly
which residues are involved and, considering again the likely timescale of
successive phosphorylation/dephosphorylation events compared with that
for NFAT translocation, for the purposes of this model, a single step is
assumed.
Finally, it was assumed that both the cytosolic and nuclear phosphoryla-
tion-dephosphorylation reactions (R1 and R3) are reversible. It should be
noted that the existence of the associated back-reactions is not experimen-
tally confirmed. The nuclear import-export reactions (R2 and R4, respec-
tively) do not have back reactions, as these use the Ran cycle and are active
processes and therefore unlikely to run backward in this context.
With these assumptions, reactions R1–4 were formulated according to the
law of mass action. Reaction R1 depicts the binding to and dephosphoryla-
tion of NFATpc by activated calcineurin to form the complex NFATNc,
NFATpc þ Nactive#
kf;1
kr;1
NFATNc;
where Nactive is the amount of activated calcineurin, determined by the
relation
Nactive ¼ Ntot  actN;
where actN is the fraction of activated calcineurin,
actN ¼ Ca
n
Can þ ðKm;NÞnð1 þ Kd;1M
:
Here Ca is intracellular calcium concentration; n is the calcineurin activation
Hill coefficient; Km, N is the half-maximal activation concentration of calcium
for calmodulin activation for a given concentration of calmodulin (M); and
Kd, 1 is the calcineurin-calmodulin dissociation constant (see the Supporting
Material for the derivation of this equation). The back-reaction embodies
the deactivation of calcineurin (which is dependent on the calcium concen-
tration) and dissociation of the calcineurin-NFAT complex allowing NFAT
to be rephosphorylated. In this formulation, these are modeled as a single
step, where the amount of NFAT/calcineurin complex available to be disso-
ciated is proportional to (1-actN). The flux equation for this reaction is,
therefore,
J1 ¼ kf; 1  NFATpc  Ntot  actN  kr; 1  NFATNc
 ð1 actNÞ:
Similarly, the nuclear rephosphorylation reaction (R3) is
NFATNn#
kf;3
kr;3
NFATpn þ Nactive
(note that since the predominant direction for reaction R3 is right-to-left in
Fig. 1, this reaction appears backward compared to the figure) and is formu-
lated by scaling the appropriate reactants by actN and (1  actN), to yield the
flux equation,
J3 ¼ kf; 3  NFATNn  ð1 actNÞ  kr; 3  NFATpn
 Ntot  actN:
The nuclear import and export reactions are modeled using simple
kinetics, consisting of first-order rate equations. The import process (R2) isNFATNc/
kf;2
NFATNn;
giving the flux
J2 ¼ NFATNc  kf; 2:
Similarly, the export reaction (R4) is
NFATNpn/
kf;4
NFATpc;
giving the flux
J4 ¼ NFATpn  kf; 4:
Having defined the fluxes for each of the reactions in the model, one can
derive expressions for the rates of change of the molecular species. The cyto-
solic phosphorylated NFAT is involved in both reactions R1 and R4, thus
dðNFATpcÞ
dt
¼ J4
Ccn
 J1:
The scaling by Ccn on nuclear export adjusts for the difference in volume
of the nucleus compared to the cytosol. The cytosolic dephosphorylated
NFAT is involved in both reactions R1 and R2, thus
dðNFATNcÞ
dt
¼ J1  J2:
The nuclear dephosphorylated NFAT is involved in both reactions R2 and
R3, thus
dðNFATNnÞ
dt
¼ J2  Ccn  J3:
The nuclear phosphorylated NFAT is involved in both reactions R3 and
R4, thus
dðNFATpnÞ
dt
¼ J3  J4:
This gives a simple mathematical formulation of the NFAT cycle. Six rate
parameters (kf,1, kr,1, kf,2, kf,3, kr,3, and kf,4) are unknown. The model was
therefore fitted to experimental data to determine whether this formulation
could act in a physiologically meaningful way.
Model ﬁtting
Experimental nuclear NFAT transients in skeletal myocytes are presented in
the recent study of Shen et al. (11). The researchers make a number of
measurements of total nuclear NFAT to explore the nuclear export system
under various conditions (experimental measurements distinguishing
between dephosphorylated and phosphorylated nuclear NFAT do not appear
to have been conducted, as yet, in any cell type). Since other available
studies of this type are in nonexcitable cells (for example, (15,28)) this skel-
etal myocyte data was chosen as the primary dataset to fit the model to, being
derived from the closest available cell type to the cardiac myocyte.
Shen et al. applied electrical stimulation (mimicking that found during
physiological activation of slow muscle fibers) for 60 min, and measured
NFAT translocation to the nucleus with a range of different protein inhibi-
tors to determine the major effectors of NFAT nuclear efflux during the
resulting calcium oscillations. The measure is expressed as a percentage
of nuclear NFAT compared to the value at 60 min. Translocation was stim-
ulated for 60 min, after which time a calcineurin inhibitor was introduced
leading to a decline in nuclear NFAT (11). Nuclear NFAT transients varied
between experiment, so to provide measures of NFAT translocation under
normal conditions, control data from 12 of their figures (specifically (11),Biophysical Journal 96(6) 2095–2104
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were digitized and aggregated.
The simulation protocol in the study of Shen et al. (11) applied 5 s trains
of 10 Hz electrical pulses, occurring with a period of 50 s. The calcium
response to the electrical pulse was assumed to be similar to previous studies
from which the protocol was derived (29,30) in skeletal muscle fibers. In
those experiments, a 93 nM baseline calcium rose to 1121 nM in 16 ms
before returning to baseline levels in ~120 ms. During the 10-Hz pulse train
in the study of Shen et al., the calcium would not have enough time, post-
stimulation, to return to baseline levels; however, it would, at the experimen-
tally determined rate of decline, reach 291 nM before rising again. Hence,
a sawtooth pattern rising from 291 nM to 1121 nM in 16 ms, and declining
again to 291 nM in 84 ms, was used to approximate the calcium levels
during stimulation trains (see Appendix for equations describing the calcium
stimulation, and the Supporting Material for a graphical depiction).
The calcium protocol was imposed for 60 min after which calcineurin inhib-
itor was added. This inhibition was assumed to follow first-order kinetics,
Nactive/
k
Ninactive;
which leads to exponential decay of the calcineurin activity,
actN ¼ actN  e
ðtimestimEndTimeÞ
tN if tRstimEndTime;
actN otherwise
(
where stimEndTime ¼ 3600 s and tN is an unknown calcineurin inhibition
time constant, included as an additional parameter in the fitting process. This
inhibition reduces the influence of calcineurin in both the cytosol and the
nucleus on the addition of inhibitor, leading to a decline in nuclear NFAT.
It has also been shown recently by Tomida et al. (15) that, during NFAT
cycling, the reaction rates from one state to another are such that dephos-
phorylated NFAT (NFATNc in Fig. 1) builds up in the cytosol before being
translocated to the nucleus. To ensure that the model replicates this behavior,
data from Tomida et al. for both cytosolic dephosphorylated NFAT and
nuclear NFAT, produced under a constant calcium stimulation, were digi-
tized and used in the fitting process.
The protocol used in the experiments of Tomida et al. consisted of
a constant calcium stimulation. The authors of that study suggested simulating
with a transient similar to theirs ((15); Fig. 1 D, that article; and personal
communication, 2007). Digitizing values from this, calcium was modeled
as a step increase from 60 nM, causing an initial rise to 576 nM falling to
334 nM gradually over 18 min, then holding at that level until 30 min of
stimulation had elapsed.
FIGURE 2 Simulated NFAT fits experimental results from Shen et al.
(11). The bar in the lower left shows calcium stimulation duration.
Biophysical Journal 96(6) 2095–2104In terms of nuclear percentage NFAT, the two datasets taken together give
inconsistent results. Since the dataset of Shen et al. (11) is the primary model
fitting set, a scaling factor was applied to the data of Tomida et al. (15) to
make the datasets more compatible (see Supporting Material for details).
Parameter fitting was then performed by replicating the calcium protocols
from each of the studies (11,15), and using the Levenburg-Marquardt algo-
rithm (implemented as the ‘‘levmar’’ nonlinear least-squares fitting package,
obtained from http://www.ics.forth.gr/~lourakis/levmar). The model was run
to steady state with first 93 nM (11) and then 60 nM (15) calcium, and fitting to
both protocols was done, respectively, from the appropriate steady-state value
with each unknown kinetic rate constant allowed to vary between 1  1012
and 1  101. Goodness-of-fit was calculated as the sum of the squared
percentage differences between target and simulated values.
The best fit was achieved with the parameters listed in Table 2, giving
a good fit to the data of Shen et al. under that protocol, as shown in Fig. 2.
In addition, the fit to the data of Tomida et al. was qualitatively similar to
experiments, as shown in Fig. 3. This shows that cytosolic dephosphorylated
NFAT is buffered before declining, while nuclear NFAT occurs as a steady
rise, similar to the effect observed experimentally (15). Model equations
and fitted parameters can be found in the Appendix and Table 2, respectively.
A complete list of mathematical equations for the NFAT cycling model
under the experimental protocols (derived from (11,15), and under dual
calcium signals as discussed below) is given in the Appendix. Parameters
and initial conditions are listed in Table 2, where ‘‘(Fitted value)’’ denotes
that the parameter value was derived from the fitting process described
TABLE 2 NFAT cycling model parameters and initial
conditions
Symbol Units Value Source
Ccn Dimensionless 50.0 (see Methods)
Kd,1 nM 1760 (see Supporting Material)
kf,1 nM
1.s1 7.69  106 (Fitted value)
kr,1 s
1 1.93  102 (Fitted value)
kf,2 s
1 1.44  103 (Fitted value)
kf,3 s
1 3.62  104 (Fitted value)
kr,3 nM
1.s1 4.71  105 (Fitted value)
kf,4 s
1 4.45  104 (Fitted value)
Km,N nM 535 (see Supporting Material)
M nM 6000 (21)
n Dimensionless 2.92 (see Supporting Material)
Ntot nM 1000 (21)
Steady-state values of the NFAT species depend on the protocol applied.
For the protocol of Shen et al. (11) and the dual-calcium protocol, use
NFATpc nM 9.83  101 (Steady-state)
NFATpn nM 2.76  101 (Steady-state)
NFATNc nM 1.70  103 (Steady-state)
NFATNn nM 5.09  101 (Steady-state)
For the protocol of Shen et al. (11) only
tN s 7.01  102 (Fitted value)
tN, inhib s 3600 (Protocol)
trainPeriod s 50.0 (Protocol)
stimEnd s 3600 (Protocol)
For the dual-calcium protocol only
period s > 0.017 (User-defined)
For the protocol of Tomida et al. (15), use
NFATpc nM 9.96  101 (Steady-state)
NFATpn nM 7.79  102 (Steady-state)
NFATNc nM 4.81  104 (Steady-state)
NFATNn nM 1.09  101 (Steady-state)
stimEnd s 1800 (Protocol)
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the model in modularized CellML (31) for all three protocols can be found in
the online CellML Repository (http://www.cellml.org/models).
Note that in Table 2 the nuclear NFAT concentrations (NFATNn and
NFATpn) are given in terms of the nuclear volume. The model steady-state
values are used as initial conditions (rather than the initial conditions from
one of the experimental datasets), as it is the transient behavior that is of
interest, and this best assessed from steady state.
RESULTS
Model behavior was compared with experimental results to
assess the validity of the model. Specifically, the effects of cal-
cineurin overexpression, constituent activation and calcium
oscillations were investigated.
While elucidating the link between calcineurin and NFAT
cycling, it was noted (32) that NFAT activation (as measured
by a reporter gene) occurs more readily with overexpressed
calcineurin even when the level of calcium is held constant.
Additionally, research has shown that NFAT cycling occurs
in the absence of calcium when calcineurin is engineered to
be constituently active (33,34). These effects were explored
in the model by setting the calcium level to a resting state of
100 nM, then increasingNtot in the case of calcineurin overex-
pression, or by setting Nact to 1.0 to simulate the constituently
active enzyme, respectively. As a proxy for NFAT activation,
the amount of available dephosphorylated (and hence DNA-
ready) NFAT in the nucleus (state NFATNn) was used. As
can be seen in Fig. 4, the experimental findings are qualita-
tively replicated by model simulations of calcineurin overex-
pression (DNA-ready NFAT rises to 100% as calcineurin is
overexpressed).
In the case of constituently active calcineurin, simulations
showed that dephosphorylation of nuclear NFAT is completely
inhibited and the percentage of active NFAT is 100%, even
with no calcium in the system (data not shown), as one would
expect from the aforementioned experimental results.
FIGURE 3 Simulated NFAT and calcium transients during the protocol of
Tomida et al. (15).In nonexcitable cells such as lymphocytes, NFAT cycling is
stimulated by calcium oscillations. Dolmetsch et al. (28)
measured NFAT translocation via the percentage of a popula-
tion of cells exhibiting NFAT-induced expression of a lacZ
reporter gene, and discovered that for low levels of calcium,
oscillating calcium concentrations stimulate NFAT cycling
more efficiently than a constant calcium signal of the same
average concentration (see (28), and Fig. 2 c in that article).
This result can be replicated in the model. Digitizing calcium
spikes provided in Dolmetsch et al. (28) to determine the
mean peak for two given average calcium concentrations—
a 776 nM peak for an average of 227 nM, and 1272 nM for
an average of 340 nM. Approximating the calcium pulses by
a step function from the average basal value (57 nM) and using
the information that pulses were of 100-ms duration, an estima-
tion of peak time for the step function of 23.5 ms was made (in
both cases, this gives the appropriate average calcium level).
The required peak for each measured oscillating-calcium data
point in the Dolmetsch experiment could then be calculated,
to give the appropriate average as per the experimental protocol.
The peak concentration of oscillating calcium required to
replicate the experiment having been determined, the model
was run to steady state for a variety of both constant and
oscillating calcium treatments. The results are displayed in
Fig. 5, showing very similar qualitative behavior to the
experimental results (compare also our simulated curves
with the lines of best fit in (28), and in Fig. 2 c, that article).
While the absolute level of activation is higher, the curves
appear similarly shaped and crossover at approximately the
same level of average calcium: at ~365 nM in the simulated
results, compared to the experimentally measured figure of
375 nM (estimated from (28), and Fig. 2 c, that article).
This comparative efficiency when stimulated by oscilla-
tions is due to the balance of the kinetics of the system. Cyto-
solic dephosphorylated NFAT (NFATNc) translocates to the
nucleus relatively slowly and builds up during stimulation.
FIGURE 4 Simulated DNA-ready NFAT increases as calcineurin is over-
expressed.
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2100 Cooling et al.When stimulation is removed during the oscillation cycle, this
NFAT reduces again but does not have time to return to the
same level as at the start of the oscillation. The next oscillation
can therefore push the peak cytosolic dephosphorylated
NFAT even higher. This iterative increase has a similar
knock-on effect on the levels of dephosphorylated nuclear
(DNA-ready) NFAT (NFATNn). Thus while the average level
of calcium may remain the same as in a constant signal, the
system can take some advantage of the higher peak calcium
provided by an oscillatory protocol.
The activation of NFAT also decreases as the period of the
oscillation increases, as shown experimentally by Dolmetsch
et al. ((28), and Fig. 3 b, that article). This effect is replicated
by the model simulation results in Fig. 6 and is qualitatively
similar to the experimental findings, although the model was
FIGURE 5 Simulated NFAT activation for oscillating and constant
calcium levels is qualitatively similar to experimental results, with simulated
lines matching best-fit lines in ((28), and Fig. 2 c, that article). Experimental
data is from that same figure.
FIGURE 6 Simulated % DNA-ready NFAT with increasing calcium
oscillation period is qualitatively similar to experimental results. Experi-
mental data is from ((28), and Fig. 3 b, that article).
Biophysical Journal 96(6) 2095–2104not quite as sensitive to changes in oscillation period as was
observed in the experimental data.
Sensitivity to signal transduction
In nonexcitable cells such as lymphocytes, the IP3/calci-
neurin pathway is known to stimulate calcium oscillations
(28). In contrast, the cardiac myocyte already exhibits
calcium oscillations (35) from ~100 nM to 1 mM, due to
the excitation-contraction coupling mechanism of the cardiac
myocyte beat (20).
Different types of myocytes have different excitation-
contraction coupling calcium transients and signal transduc-
tion calcium transients. Experiments in neonatal rat cardiac
myocytes indicate that stimulation with hypertrophic agonist
in the periodically stimulated cardiac myocyte leads to a sus-
tained rise in both diastolic and systolic calcium levels ((36),
and Fig. 3 b, that article), essentially adding a constant rise in
calcium concentration from extracellular calcium. There is
also strong evidence for a rise in intracellular calcium from
outside the cell in rat adult ventricular myocytes (37).
To simulate these signals, calcium-induced calcium-
release calcium oscillations (CaBeat) and a stepwise constant
increase in cytosolic calcium due to signal transduction
(CaSigTrans) were imposed on the model, redefining calcium as
Ca ¼ CaBeat þ CaSigTrans:
Cardiac myocyte calcium oscillations due to excitation-
contraction coupling differ between species. For the
purposes of this investigation, the oscillations were assumed
to follow the same waveform as that used above in the
protocol of Shen et al. ((11), and see Appendix, this article,
for details). To explore the sensitivity of the model to
constant hypertrophic signals against a background of oscil-
lating beat calcium, CaSigTrans was varied from 0 mM (no
hypertrophic stimulation) to 1 mM for a range of CaBeat
pacing frequencies and the system run to steady state for
each condition. The proportion of NFAT in the DNA-ready
state NFATNn (nuclear, dephosphorylated) was used as
a proxy for hypertrophic DNA activation.
Fig. 7 shows the increasing sensitivity of DNA-ready NFAT
production to step increases in calcium concentration during
calcium oscillations. The increase to nearly 100% production
over the first 500 nM of calcium for a range of pacing frequen-
cies shows that the NFAT cycling system is sensitive to the
type of calcium signal one might expect from the hypertrophic
pathway, even against an oscillating background.
DISCUSSION
The parsimonious model developed above was able to fit
experimental results in the skeletal myocyte, and the fitted
model exhibits behavior (with respect to total nuclear and
cytosolic-dephosphorylated NFAT) qualitatively similar to
Calcium Sensitivity of NFAT Cycling 2101that measured in lymphocytes. In addition, the model quali-
tatively replicates experimentally observed behavior during
constitutive activation by calcineurin, oscillating calcium,
and variation of calcium oscillation period. When stimulated
by two calcium signals, one corresponding to the cardiac
myocyte beat and the other corresponding to a hypertrophic
signal, the system is shown to be sensitive to the second
signal, even when both calcium signals are in the same
cellular compartment.
Some researchers have postulated that the hypertrophic
pathway is always ‘‘on’’ to some degree even without
hormonal stimulation (38), due to this background oscillation.
The result shown in Fig. 7 supports this view, as some
percentage of NFAT is always DNA-ready. More surprisingly,
the figure also indicates that under the assumptions of the
model, the NFAT system is very sensitive to a sustained step
change in calcium with a background oscillating calcium level.
This is likely to be due to the sensitivity of calcineurin to
calcium over the range tested. Stemmer and Klee (39) illus-
trated that for physiological (in the cardiac myocyte) values
of calmodulin, the calcineurin activation curve is most sensitive
to calcium ions between pCa 6.7 and 5.8 (~200 nM to 1.58mM).
The average calcium level under the protocol applied here
varies as shown in Table 1. The table shows that the protocol
explores this sweet spot in the calcineurin activation curve.
The average calcium level increases markedly as the
hypertrophic signal raises both systolic and diastolic calcium
levels. Additionally, the sensitivity of calcineurin to calcium
over this range (shown by Nact) increases nonlinearly, partic-
ularly for CaSigTrans values <250 mM. The short timescale for
calcineurin activation, coupled with the nonlinear sensitivity
to calcium levels, ensures that NFAT cycling is influenced
by relatively small signal transduction-induced rises even
in the presence of a background oscillating calcium signal.
The model developed in this study does have several limi-
tations. Firstly, the model was fitted to noncardiac data. We
FIGURE 7 Simulated NFAT cycling sensitivity to CaSigTrans during
calcium oscillations.have used myocyte data as our primary dataset (skeletal
muscle), combined with qualitative fits to BHK data, and
replication of key behaviors from other cell types. Model
precision could, however, be enhanced by fitting to explicitly
cardiac-derived data under similar protocols to those used in
Shen et al. (11) and Tomida et al. (15), as such data becomes
available. There may also be species differences—for
example, in rabbit ventricular myocytes, a-adrenergic stimu-
lation seems to increase systolic, but not diastolic, calcium
(40), whereas there is evidence for sustained calcium eleva-
tion in adult rat ventricular myocytes (37). Additionally,
stimulation in experiments in adult ventricular myocytes
yields a calcium spike of sufficient magnitude to affect
NFAT cycling, which has not been modeled here. It is there-
fore possible that a more complete picture of adult ventric-
ular myocyte NFAT cycling could be derived by accounting
for these effects. Here we considered a simple case, which
adequately explores the question of interest.
Currently, since the exact concentration of free versus
NFAT-bound calcineurin is not explicitly tracked, there is
no possibility of calcineurin becoming saturated with
NFAT and being unable to dephosphorylate any more.
This saturation may occur if the total NFAT concentration
was greater than the total calcineurin concentration (which
was set to 1 mM). There is no reliable measure of NFAT
concentration in cardiac myocytes, but if it was found to
be higher than that value, then this limitation should be
addressed. The simplest way would be to track calcineurin
separately in both nuclear and cytosolic compartments.
One modeling study (21) indicates that calcineurin activation
may, at high calcium oscillation frequencies, be an accumu-
lative process. Given further experimental research in this
area, these extensions, if applicable, would require a time-
dependent model of calcium activation of calcineurin, and
a more explicit formulation of the communication of free cal-
cineurin between the cytosol and nucleus. These have not
been done in this study so as not to complicate the model
with extra processes containing high levels of uncertainty.
While model results fit the data from Shen et al. (11) when
that data is considered in aggregate, many of the experiments
suggest that post-stimulation (after the 60-min mark) nuclear
NFAT continues to rise before declining. The model does
exhibit this behavior to a small degree (too small to see clearly
in Fig. 2), but it is possible that this feature should be empha-
sized to reflect the reality in vivo. A possible mechanistic
reason for this effect could be the cytosolic dephosphorylated
NFAT buffering shown by the experiments ((15), and Fig. 2 b,
that article), which was not as great in our fitted simulations,
and would provide more import-ready NFAT to increase the
nuclear transient after stimulation had ceased.
A feature of the dataset of Tomida et al. (15), which has
not been replicated by the model above, is the cytosolic
dephosphorylated NFAT (NFATNc) transient’s apparent
return to pre-calcium-stimulated levels after ~30 min even
though calcium is still raised (see (15), and Fig. 2 b, thatBiophysical Journal 96(6) 2095–2104
2102 Cooling et al.article). This raises the intriguing possibility of the presence of
an adaptive mechanism in the cytosol with respect to NFAT
cycling. There has been a recent focus on an endogenous cal-
cineurin inhibitor MCIP (modulatory calcineurin interacting
protein), although this protein is known also to facilitate
hypertrophy under certain conditions, with recent modeling
work hypothesizing a critical nuclear NFAT threshold neces-
sary to cause MCIP to act as a calcineurin inhibitor in the
cytosol (14). If that is true, MCIP may perhaps be a candidate
for an adaptive mechanism. The details of MCIP activity
remain somewhat speculative, and so have not been included
in this model. If NFAT transient data were collected from
cardiac myocytes and this apparently adaptive effect was
also shown, the inclusion of MCIP in the model formulation
may drive further fruitful investigation.
Finally, the modeled system is slightly more sensitive to
calcium oscillations than was reported in the experimental
results. Fig. 5 shows efficiency even at low calcium of
~88%, whereas experimental results indicate an activation
level of ~38% ((28), and Fig. 2 c, that article). It is possible
that this may be because two different effects are being
measured—the simulation results measure the percentage
of NFAT available to bind to the DNA (the proportion in
the NFATNn state), while the experimental data shows the
percentage of cells expressing a reporter gene under those
conditions. In reality, between these two measures lie the
actual binding of NFAT to the DNA and transcription and
translation of the reporter sequences. Incorporation of these
additional biological processes is expected to reduce the
model’s apparent oversensitivity.
While some evidence is emerging that nuclear calcium tran-
sients may be involved (41,42), the model is used to explore
the implications of both calcium signals being in the same
compartments. In the model, full DNA-ready NFAT produc-
tion occurs within the first 500 nM of signal transduction-
induced calcium. An exact calibrated figure for the average
calcium concentration rise due to hypertrophic stimulation
is not available from the literature, but this work strongly indi-
cates that in the cardiac myocyte, even a small increase in
calcium due to signal transduction has a large effect on
NFAT activation. The excitation-contraction calcium tran-
sient does not wash out the hypertrophic calcium signal, and
separate compartments for excitation-contraction and excita-
tion-transcription coupling calcium signals may not be
required. Conversely, if it was found that nuclear localization
does indeed play a part, the reason for this may not be the
intuitively simple one of keeping the two calcium signals
separated.
Here we have imposed a calcium oscillation to investigate
the impact on hypertrophic signal. Further insights might be
gained by the analysis of future models coupling all cytosolic
calcium signal pathways in the cardiac myocyte, examining
the effect of the hypertrophic signal on other cellular
processes that produce or consume calcium.
APPENDIX—FORMULATION OF CaBeat
The ability to define the period of the oscillations in milliseconds was added,
by introducing a parameter period (measured in seconds). The inverse of this
is the variable ms_in_pulse defined as the number of milliseconds the system
is into a pulse of period, designated period. The protocol assumes an
upstroke of 16-ms duration, followed by a return to baseline levels during
the remaining time of the oscillation:
stimGradient and baseline are calculated from the period. The term baseline
is the resting calcium level, and is dependent on period as rapid oscillations
(<120 ms_in_pulse) will mean that calcium would not have time to reach
the basal level of 93 nM again before the next upstroke. To account for
this, if the period is <120 ms, the model calculates the oscillation baseline
calcium from the known gradient (9.88 nM.ms1 (3 significant figures)) of
the downstroke multiplied by the time between the peak and the end of the
period (the peak is 16 ms after the start of the rise):
CaBeat ¼
ðms in pulse  stimGradient þ baselineÞ; if ms in pulse%16;
ððms in pulse 16Þ  9:8846 þ 1121Þ; ifðms in pulse > 16Þ^
ðms in pulse%120Þ;
baseline otherwise:
8><
>>:
FIGURE 8 Simulated calcium oscillations for several values of period
and CaSigTrans.
baselineðnMÞ ¼ 93; if periodR0:12;ð1121 þ ðperiod  1000  16Þ  9:8846Þ otherwise:

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1121 nM in 16 ms,
stimGradient ¼ ð1121  baselineÞ
16
where stimGradient is measured in nM.ms1. The resulting calcium
transient for several values of period (and CaSigTrans, other component of
Ca) are shown in Fig. 8.
Note that CaBeat as formulated is only valid for oscillation periods
of R17 ms (~59 Hz). However, this should be flexible enough for any
mammal of interest.
Myocyte NFAT model equations for Shen et al.
(11), Tomida et al. (15), and dual-calcium protocols
For the protocol of Shen et al. only, add
actNapp ¼
actN if t < tN;inhib;
actN  e
ðttN;inhibÞ
tactN if tRtN;inhib:
(
Also, replace actN in Eqs. 1 and 2 (due to calcineurin inhibitor introduc-
tion).
The calcium equations depend on the protocol being used.
For the protocol of Shen et al., use
timeInStim mPulseP ¼ t  floor
 t
0:1

 0:1;
timeInStim mTrainP ¼ t  floor
 t
trainPeriod

 trainPeriod:
For the protocol of Tomida et al., use
Ca ¼
117  t
180
þ 576; ifðtR0Þ^ðt%180Þ;
53  ðt  180Þ
180
þ 459; ifðt>180Þ^ðt%360Þ;
29  ðt  360Þ
180
þ 406; ifðt>360Þ^ðt%540Þ;
29  ðt  540Þ
180
þ 377; ifðt>540Þ^ðt%720Þ;
12  ðt  720Þ
180
þ 348; ifðt>720Þ^ðt%900Þ;
2  ðt  900Þ
180
þ 336; ifðt>900Þ^ðt%1080Þ;
334; ifðt>1080Þ^ðt%stimEndÞ;
60 otherwise:
8>>>>>>>>>><
>>>>>>>>>>>:
For the dual-calcium protocol, use
ms in pulse ¼ 1000 ðtime floor

t
period

 periodÞ;
stimGradient ¼ ð1121  baselineÞ
16
:
SUPPORTING MATERIAL
Six figures are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(09)00309-9.
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actN ¼ Ca
n
Can þ ðKm;NÞnð1 þ Kd;1M

J1 ¼ kf;1  NFATpc  Ntot  actN  kr;1
NFATNc  ð1 actNÞ ð1Þ
J2 ¼ kf;2  NFATNc
J3 ¼ kf;3  NFATNn  ð1 actNÞ  kr;3
NFATpn  Ntot  actN ð2Þ
J4 ¼ kf;4  NFATpn
dðNFATNcÞ
dt
¼ J1  J2
dðNFATNnÞ
dt
¼ J2  Ccn  J3
dðNFATpcÞ
dt
¼ J4
Ccn
 J1
dðNFATpnÞ
dt
¼ J3  J4
:
Ca ¼
1000  ðtimeInStim mTrainP 5Þ  9:8846 þ 290:69;
ifðtimeInStim mTrainPR5Þ^ðtimeInStim mTrainP%5:02Þ^ðt < stimEndÞ;
1000  timeInStim mPulseP  51:894 þ 290:69;
ifðtimeInStim mTrainP < 5Þ^ðtimeInStim mPulseP%0:016Þ^ðt < stimEndÞ;
1000  ðtimeInStim mPulseP  0:016Þ  9:8846 þ 1121;
ifðtimeInStim mTrainP < 5Þ^ðtimeInStim mPulseP > 0:016Þ^ðt < stimEndÞ;
93
otherwise:
8>>>>><
>>>>>:
baseline ¼
93; if periodR0:12;
1121 þ ðperiod  1000
16Þ  9:8846 otherwise:
8<
:
Ca ¼ CaBeat þ CaSigTrans
CaBeat ¼
ms in pulse stimGradient þ baseline;
if ms in pulse%16;
ðms in pulse 16Þ  9:8846 þ 1121;
ifðms in pulse > 16Þ^ðms in pulse%120Þ;
baseline
otherwise:
8>>><
>>>>:
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